Healthcare Equipment and Supplies
Company Overview of Corindus Vascular Robotics, Inc.
Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures. Its CorPath system facilitates stent positioning for PCI procedures by allowing a physician to measure, manipulate, and advance devices with robotic precision; and CorPath GRX system enables the precise robotic-assisted control of coronary guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The compan...
309 Waverley Oaks Road
Waltham, MA 02452
Key Executives for Corindus Vascular Robotics, Inc.
President, CEO & Director
Total Annual Compensation: $458.0K
CFO, Senior VP, Secretary & Treasurer
Total Annual Compensation: $404.0K
Senior VP & GM of Peripheral Intervention Segment
Total Annual Compensation: $69.0K
Compensation as of Fiscal Year 2016.
Corindus Vascular Robotics, Inc. Key Developments
Corindus Vascular Robotics, Inc. announced delayed annual 10-K filing
Mar 19 18
On 03/19/2018, Corindus Vascular Robotics, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
Corindus Vascular Robotics, Inc. Elects Douglas L. Braunstein as Class I Director
Mar 16 18
On March 15, 2018, the board of directors of Corindus Vascular Robotics, Inc. elected Douglas L. Braunstein, effective as of the closing of the financing, to serve as a Class I director until the 2020 annual meeting of stockholders, or his earlier death or resignation or until his successor is duly elected and qualified. Since 2015, Mr. Braunstein has served as the managing partner and founder of Hudson Executive Capital. Previously, Mr. Braunstein served in various roles at JPMorgan Chase & Co., including as vice chairman and chief financial officer. Mr. Braunstein will be compensated as a non-employee director in accordance with the company’s non-employee director compensation policy, as amended on December 15, 2018.
Corindus Vascular Robotics, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2017
Mar 14 18
Corindus Vascular Robotics, Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2017. For the quarter, the company reported revenue was $4,190,000 against $538,000 a year ago. Revenue in the quarter was driven primarily by CorPath GRX Systems and capital upgrade sales. Operating loss was $7,982,000 against $9,609,000 a year ago. Net loss was $7,971,000 against $9,791,000 a year ago. Net loss per share--basic and diluted was $0.04 against $0.08 a year ago.
For the full year, the company reported revenue was $9,650,000 against $2,842,000 a year ago. Operating loss was $33,909,000 against $32,077,000 a year ago. Net loss was $34,123,000 against $33,078,000 a year ago. Net loss per share--basic and diluted was $0.2 against $0.28 a year ago.
Similar Private Companies By Industry
Recent Private Companies Transactions
March 15, 2018